Potential Clinical Impact of Compounded Versus Noncompounded Intrathecal Baclofen
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 90 (11) , 1815-1820
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Multistate Outbreak of Serratia marcescens Bloodstream Infection Associated with Contaminated Intravenous Magnesium Sulfate from a Compounding PharmacyClinical Infectious Diseases, 2007
- Quality of Extemporaneously Compounded Nitroglycerin OintmentDiseases of the Colon & Rectum, 2007
- Intrathecal Baclofen Management of Poststroke Spastic Hypertonia: Implications for Function and Quality of LifeArchives of Physical Medicine and Rehabilitation, 2006
- Outbreak ofSerratia marcescensInfections following Injection of Betamethasone Compounded at a Community PharmacyClinical Infectious Diseases, 2006
- Life-Threatening Sepsis Caused by Burkholderia cepacia From Contaminated Intravenous Flush Solutions Prepared by a Compounding Pharmacy in Another StatePediatrics, 2006
- Prevalence and treatment of spasticity reported by multiple sclerosis patientsMultiple Sclerosis Journal, 2004
- Long-term intrathecal baclofen therapy for severe spasticity of cerebral originJournal of Neurosurgery, 2003
- Continuous Intrathecal Baclofen Infusion by a Programmable Pump in 131 Consecutive Patients with Severe Spasticity of Spinal OriginNeuromodulation: Technology at the Neural Interface, 2002
- Intrathecal Baclofen for Spastic Hypertonia From StrokeStroke, 2001
- Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter studyJournal of Neurosurgery, 1993